Systemic lupus erythematosus primary prevention: Difference between revisions

Jump to navigation Jump to search
Line 11: Line 11:
===Prevention of complications during pregnancy===
===Prevention of complications during pregnancy===


While most infants born to mothers who have SLE are healthy, pregnant mothers with SLE should remain under a doctor's care until delivery. Neonatal lupus is rare, but identification of mothers at highest risk for complications allows for prompt treatment before or after birth.  In addition, SLE can flare during pregnancy, and proper treatment can maintain the health of the mother longer. Women pregnant and known to have the antibodies for anti-Ro (SSA) or anti-La (SSB) should have echocardiograms during the 16th and 30th weeks of pregnancy to monitor the health of the heart and surrounding vasculature.<ref name=niams/>
While most infants born to mothers who have SLE are healthy, pregnant mothers with SLE should remain under a doctor's care until delivery. Neonatal lupus is rare, but identification of mothers at highest risk for complications allows for prompt treatment before or after birth.  In addition, SLE can flare during pregnancy, and proper treatment can maintain the health of the mother longer. Women pregnant and known to have the antibodies for anti-Ro (SSA) or anti-La (SSB) should have echocardiograms during the 16th and 30th weeks of pregnancy to monitor the health of the heart and surrounding vasculature.


Even [[contraception]] was routinely advised in treating SLE patients, getting pregnant during active disease was eventually found. [[Lupus nephritis]] was the most common manifestation. Overall live-birth was 72.7%. Pregnancy lost was due to [[abortion]] and dead fetus in utero. Pregnancy outcome was worse in SLE patients who had disease flares up or emerging during pregnancy.<ref name="pmid19253790">{{cite journal |author=Foocharoen C, Nanagara R, Salang L, Suwannaroj S, Mahakkanukrauh A |title=Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital |journal=J Med Assoc Thai |volume=92 |issue=2 |pages=167–74 |year=2009 |month=February |pmid=19253790 |doi= |url= |issn=}}</ref>
Even [[contraception]] was routinely advised in treating SLE patients, getting pregnant during active disease was eventually found. [[Lupus nephritis]] was the most common manifestation. Overall live-birth was 72.7%. Pregnancy lost was due to [[abortion]] and dead fetus in utero. Pregnancy outcome was worse in SLE patients who had disease flares up or emerging during pregnancy.<ref name="pmid19253790">{{cite journal |author=Foocharoen C, Nanagara R, Salang L, Suwannaroj S, Mahakkanukrauh A |title=Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital |journal=J Med Assoc Thai |volume=92 |issue=2 |pages=167–74 |year=2009 |month=February |pmid=19253790 |doi= |url= |issn=}}</ref>

Revision as of 20:29, 2 August 2012

Systemic lupus erythematosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Systemic lupus erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Systemic lupus erythematosus primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Systemic lupus erythematosus primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Systemic lupus erythematosus primary prevention

on Systemic lupus erythematosus primary prevention

Systemic lupus erythematosus primary prevention in the news

Blogs onSystemic lupus erythematosus primary prevention

Directions to Hospitals Treating Systemic lupus erythematosus

Risk calculators and risk factors for Systemic lupus erythematosus primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Prevention

Lupus is not understood well enough to be prevented, but when the disease develops, quality of life can be improved through flare prevention. The warning signs of an impending flare include increased fatigue, pain, rash, fever, abdominal discomfort, headache and dizziness. Early recognition of warning signs and good communication with a doctor can help individuals with lupus remain active, experience less pain and reduce medical visits.

Prevention of complications during pregnancy

While most infants born to mothers who have SLE are healthy, pregnant mothers with SLE should remain under a doctor's care until delivery. Neonatal lupus is rare, but identification of mothers at highest risk for complications allows for prompt treatment before or after birth. In addition, SLE can flare during pregnancy, and proper treatment can maintain the health of the mother longer. Women pregnant and known to have the antibodies for anti-Ro (SSA) or anti-La (SSB) should have echocardiograms during the 16th and 30th weeks of pregnancy to monitor the health of the heart and surrounding vasculature.

Even contraception was routinely advised in treating SLE patients, getting pregnant during active disease was eventually found. Lupus nephritis was the most common manifestation. Overall live-birth was 72.7%. Pregnancy lost was due to abortion and dead fetus in utero. Pregnancy outcome was worse in SLE patients who had disease flares up or emerging during pregnancy.[1]

References

  1. Foocharoen C, Nanagara R, Salang L, Suwannaroj S, Mahakkanukrauh A (2009). "Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital". J Med Assoc Thai. 92 (2): 167–74. PMID 19253790. Unknown parameter |month= ignored (help)


Template:WH Template:WS